Placenta increta is a condition characterized by abnormal adherence of the placenta owing to entire or partial absence of the decidua basalis. It is generally recognized during difficult placental removal at the time of delivery. It is a life-threatening complication of pregnancy due to massive hemorrhage, uterine perforation, and infection and thus often a hysterectomy is required. We review two cases of placenta increta conservative managed successfully by selective uterine artery embolization.
Placenta increta is a serious complication of pregnancy characterized by entire or partial defect of the decidua basalis, and by the incomplete development of the fi brinoid (Nitabuch's) layer; it results in abnormally invasive implantation of placenta. Although it is considered a rare occurrence with a prevalence of approximately 1 in 2,500-7,000, it is associated with high morbidity and sometimes with a lethal outcome, mainly as a result of massive hemorrhage, uterine rupture and infections [1] . Placenta increta associated with increased maternal morbidity and mortality, generally requires Cesarean hysterectomy. Since this result in loss of fertility preservation, especially in cases who want to preserve future fertility, conservative approaches are desirable.
Case Reports

Case 1
A 27-year-old woman, gravid 2, para 1, was referred to the Department of Obstetrics and Gynecology at the University of Chonbuk with a diagnosis of placenta percreta. She had a history of a fi rst trimester surgical termination of pregnancy and no signifi cant previous medical history. She underwent elective low segment Cesarean section 2 hours ago at a private hospital and delivered a healthy infant weighing 2,370 g at 40 weeks of gestation. Intraoperatively following the delivery of her fetus, placenta was identifi ed to have grown through the uterine wall with an intact uterine serosa (Fig. 1) . Therefore a manual removal of placenta was not performed. She was referred for further management. On admission, her blood pressure was 120/80 mm Hg, body temperature 36.7 o C, and pulse rate 108 beats/min. Physical examination showed minimal vaginal bleeding and uterine good contraction. Her haemoglobin was 10.3 g/dL, hematocrit 32.4%. Considering the hemodynamically stable condition, we decided to manage conservatively. Both uterine arteries embolization (UAE) was performed immediately. Supportive measures, like blood transfusion and broad spectrum antibiotics, initiated. Uterotonic drugs, including oxytocin and methylergonovine were given continuously for 2 days. Transabdominal sonogram on the second day after operation showed retained placenta accompanied with a thin uterine wall and the anterior and posterior uterine wall was deeply invaded by the placenta at fundus (Fig. 2) . Follow-up ultrasonography showed gradual shrinkage of the placenta in the uterus. Her condition remained stable and her postoperative recovery was uneventful. Fourteen days after operation, uterine exploration and curettage procedure was performed to take out a retained placenta and a small fragment of placenta was extracted. The patient was discharged and followed-up regularly under the close observation including clinical examination and pelvic ultrasonography. The patient remained asymptomatic. Fifty days after operation, because ultrasonography revealed the placental remnant showed no signifi cant reduction in size, uterine exploration and curettage procedure was repeated. A bulky placental tissue was expelled. All tissue was examined microscopically for confi rmation of placental tissue. Seven months after operation, she was feeling well and menstruating regularly. A follow-up ultrasound examination showed a linear endometrial cavity.
Case 2
A 28-year-old woman, gravid 1, para 1, who was undergone an emergency low segment Cesarean section due to induction failure 2 hours ago at a local maternity hospital was referred to the Department of Obstetrics and Gynecology at the Chonbuk National University with massive vaginal bleeding from a intraoperatively diagnosed placenta percreta. She had no past history of abortion and no signifi cant previous medical history. She delivered a healthy infant weighing 3,240 g at term. Intraoperatively following the delivery of her fetus, the placenta was retained and fi rmly adherent to the uterus. In addition, the uterus was identifi ed to have grown through left-sided fundal wall with an intact uterine serosa (Fig. 3) . Therefore, a manual removal of placenta was not performed. On admission to our clinic two hours after operation, she was receiving 1,000 mL of fl uid infusion and 1 unit of packed red blood cells after operation. Two hours after operation, estimated blood loss was about 1,000 mL. She was pale with a blood pressure of 90/60 mm Hg and a pulse rate of 108 per minute. Laboratory da- /μL. Vaginal examination revealed active vaginal bleeding. After counseling, conservative management to retain her uterus was chosen. Immediately, she was received both UAE. High dose antibiotics (cefminox, astromicin and metronidazole) were administered to prevent secondary infection. Uterotonic drugs, including oxytocin and methylergonovine were given continuously for 3 days. After UAE procedure, she remained afebrile with no evidence of infection and had no vaginal bleeding after a few days of minimal vaginal bleeding. Transabdominal sonogram on the eighth day after operation showed retained placenta and deeply invasion by the placenta at the left fundus of uterus (Fig. 4) . Fifteen days after operation, uterine exploration and curettage procedure was performed to evacuate a retained placenta. All expelled tissue was examined microscopically for confi rmation of placental tissue. Her condition remained stable, and she made a favorable progress. She was discharged and followed-up on twenty days after operation. Followup ultrasonography showed complete uterine involution and no intrauterine placental fragments (Fig. 5) .
Discussion
Placenta accreta is defi ned as an abnormally fi rm attachment of the placenta to the uterine wall with a defect of the decidua basalis. The three variants of this abnormal placentation are placenta accreta vera, increta and percreta, depending on the degree of the spectrum of abnormal placentation. Placenta accrete vera is defi ned as attachment to the myometrium without invasion into or through uterine muscle. Placenta increta involves invasion of the placenta into the myometrium. Placenta percreta represents the greatest degree of severity, including deep invasion through the entire myometrium and uterine serosa or other pelvic structures. Placenta increta is the rare form of placental abnormalities, with a 15% incidence among all placenta accreta cases [2] . Placenta accrete occurs in approximately 1 in 2,500 deliveries, and its prevalence seems to be increasing. The incidence has increased ten times over the past fifty years, reflecting the rapidly rising numbers of Cesarean section performed [3] . Other risk factors include placenta previa, advanced maternal age, multiparity, previous uterine curettage, or previous myomectomy scars [4] . Because this form of placental abnormalities can cause life-threatening severe bleeding or insuffi cient hemostasis requiring hysterectomy or death, antepartum recognition of abnormal adherent placentation is important for planning an appropriate management to a safe delivery and minimizing the risks of postpartum hemorrhage. Ultrasonography, power Doppler, and magnetic resonance imaging for prenatal diagnosis of placenta accrete are used [5, 6] . Ultrasonography is now an established fi rst-line investigation for the diagnosis of abnormal placentation and its extent. Magnetic resonance imaging is superior to ultrasonography in cases with posterior accreta or in delineating the extent of placental invasion [7, 8] . Therefore, the use of ultrasound with color Doppler imaging together with MRI in combination may be potentially effective for a diagnosis of placenta accrete. These examinations can improve the accuracy in prediction of placenta accreta and lead to more favorable outcomes. However, there is currently no consensus about these diagnostic maneuvers of placenta accreta, and the predictive value of these examinations is low [7] . Therefore, adherent placenta is often diagnosed after a failed attempt to separate the placenta from the uterus. In the case of life-threatening severe bleeding, such as placenta accreta, any delay in management may result in catastrophic complications. Hysterectomy immediately after delivery is usually preferred in an emergent situation. However, over recent decades, the conservative managements for morbidly adherent placenta have been reported, such as supplemental methotrexate or UAE. The successful treatment of placenta accrete with methotrexate by Arulkumaran et al. [9] in 1986 was fi rst reported. Henrich et al. [10] reported a complicated case of a placenta percreta in a woman infected with the human immunodefi ciency virus, which was successfully treated with the placenta left in situ and methotrexate therapy. Mussalli et al. [11] reported conservative management with methotrexate treatment resulted in uterine preservation of two of three patients and did not prevent signifi cant delayed hemorrhage. The use of UAE as an alternative management for uncontrollable post-partum hemorrhage was fi rst reported in 1979 [12] . It permits the reduction of hysterectomy rate and the preservation of fertility. Descargues et al. [13] reported that the success rate of UAE for abnormal placentation is 71%, which is lower than the success rate for postpartum bleeding. The author suggested that the conservative management with the placenta left in situ and UAE procedure in cases of abnormal placentation permits more favorable outcomes. However, because of limitation of evidence, there is no consensus of the optimal management of placenta accreta. Presently, the reported results showed varying degrees of success. Over the past 20 years, the conservative management of abnormally invasive placentation has been reviewed. In 5 of 22 women received adjuvant methotrexate, therapy failed. In 3 of twelve women managed with arterial embolization, therapy failed [14] . Therefore, it should be only considered for highly selected cases when the patient has a strong desire to retain her uterus or when blood loss is minimal [14, 15] . We describe two cases of placenta increta in which the placenta was left in situ, UAE performed and a delayed uterine exploration and curettage successfully performed. In our experience, the use of the strategy of leaving placenta in situ with adjuvant UAE as conservative management of adherent placenta is effective. However, it is important to emphasize that those women should be followed-up closely to detect complications and further studies are needed to investigate efficacy and effects of conservative techniques.
